Cholangiocarcinoma
Conditions
Interventions
Non-AI Assisted Diagnosis and Treatment Group:Non-AI Assisted Diagnosis or Treatment
AI Assisted Diagnosis and Treatment Group:AI Assisted Diagnosis and Treatment
Observation group:None
Sponsors
The second affiliated hospital of Zhejiang University school of medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Patients aged 18 to 80 years old; 2.Preoperative imaging and laboratory examinations suggest cholangiocarcinoma, confirmed by postoperative pathology (surgical patients) or puncture pathology (non-surgical patients); 3.Patients have autonomous capacity, understand and voluntarily sign written informed consent, and can complete the follow-up plan; 4.Signed written informed consent before trial screening;
Exclusion criteria
Exclusion criteria: 1.Patients with obvious cardiac, pulmonary, cerebral or renal insufficiency that affects the management of cholangiocarcinoma; 2.Patients with a history of other malignant tumors; 3.Patients deemed unsuitable for this study by the investigator;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| R0 resection rate in surgical patients;Tumor progression-free rate and disease response rate in non-surgical patients;Diagnostic accuracy of preoperative lymph node metastasis; | — |
Secondary
| Measure | Time frame |
|---|---|
| 3-year disease-free survival rate;30-day major complication rate after surgery;Surgical operation and postoperative recovery indicators;3-year overall survival rate;Tumor marker decline rate in non-surgical patients; | — |
Countries
China
Contacts
Public ContactJiangtao Li
The second affiliated hospital of Zhejiang University school of medicine
Outcome results
None listed